Yarmouk University at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Yarmouk University brings 2 presentations to IDWeek 2026 in Washington. Its program centres on drug safety signals drawn from real-world adverse event reports. It examines COVID-related adverse events in transplant recipients on immunosuppressive drugs and the side effects reported with trimethoprim-sulfamethoxazole.

OrganizationIDWeek 2026 Attendance
Yarmouk University
Irbid, Jordan
Poster
Fri Oct 23
12:15pm–1:30pm
COVID-19–Associated Adverse Event Signals in Transplant Recipients on Immunosuppressive Therapy: A FAERS Pharmacovigilance Analysis
Virtual presentation
T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs
Poster
Fri Oct 23
12:15pm–1:30pm
Trimethoprim–Sulfamethoxazole and Its Adverse Events: A Real-World Evidence Study
Virtual presentation
S6. Antibiotic Stewardship: Trends in Antimicrobial Prescribing

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Yarmouk University

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction